158 related articles for article (PubMed ID: 6468216)
1. Uncontrolled factors in controlled trials of peptic ulcer.
Bonfils S; Baron JH; Blum A
Dig Dis Sci; 1984 Sep; 29(9):858-61. PubMed ID: 6468216
[No Abstract] [Full Text] [Related]
2. [Trithiozine and peptic ulcer. Double-blind clinical study].
Catalano F; Brogna A; Blasi A
Minerva Dietol Gastroenterol; 1978; 24(3):197-201. PubMed ID: 368681
[No Abstract] [Full Text] [Related]
3. Placebo in the evaluation of antiulcer drugs.
Dobrilla G
Int J Tissue React; 1983; 5(4):329-37. PubMed ID: 6368444
[TBL] [Abstract][Full Text] [Related]
4. Double blind randomised study of tripotassium-di-citrato-bismuthate in the treatment of peptic ulcer.
Tripathi BM; Misra NP; Dube S
J Assoc Physicians India; 1984 Nov; 32(11):964-5. PubMed ID: 6396295
[No Abstract] [Full Text] [Related]
5. [Degree of objectivity in the assessment of the effect of antiulcer agents].
Geller LI
Sov Med; 1991; (6):58-60. PubMed ID: 1887308
[No Abstract] [Full Text] [Related]
6. Clinical effects of trithiozine, a newer gastric anti-secretory agent.
Pellegrini R
J Int Med Res; 1979; 7(5):452-8. PubMed ID: 387498
[TBL] [Abstract][Full Text] [Related]
7. [Clinical trial of Alcid V in peptic ulcer therapy].
Vŭrbanov G; Rusinov E; Danev I; Glinkova V; Panecheva K
Vutr Boles; 1981; 20(5):27-34. PubMed ID: 7034375
[No Abstract] [Full Text] [Related]
8. [A controlled trial of prevention of recurrence of gastroduodenal ulcers with proxybarbital].
Pol Tyg Lek; 1989 Apr 10-17; 44(15-16):364-6. PubMed ID: 2696937
[TBL] [Abstract][Full Text] [Related]
9. Ulcer complications during short-term therapy of duodenal ulcer with active agents and placebo.
Schiller LR; Fordtran JS
Gastroenterology; 1986 Feb; 90(2):478-81. PubMed ID: 3510148
[No Abstract] [Full Text] [Related]
10. [Some problems concerning the evaluation of modern contra-ulcerous drugs. Comparison of four medicaments suppressing gastric acidity (author's transl)].
Gibinski K
Cesk Gastroenterol Vyz; 1981 May; 35(3):118-22. PubMed ID: 6269763
[No Abstract] [Full Text] [Related]
11. [Therapy of peptic ulcer. Bismuth salts].
Börsch G
Verh Dtsch Ges Inn Med; 1988; 94():284-92. PubMed ID: 3061197
[No Abstract] [Full Text] [Related]
12. Sucralfate in the treatment of peptic ulcer.
Denyer ME
Practitioner; 1983 Apr; 227(1378):633-4. PubMed ID: 6344058
[No Abstract] [Full Text] [Related]
13. [Drug treatment of peptic ulcer].
Miagkova LP
Ter Arkh; 1978; 50(10):39-45. PubMed ID: 360461
[No Abstract] [Full Text] [Related]
14. Clinical course of peptic ulcer and the effect of pharmacotherapy:--multi-institutional double-blind controlled study--.
Yamagata S; Ishimori A; Satō H; Taneda T; Ishihara K
Gastroenterol Jpn; 1975; 10(4):323-41. PubMed ID: 789170
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole or misoprostol. Which works best for NSAID-induced ulcers?
Gautam M; Por CP; Evans MF
Can Fam Physician; 1998 Aug; 44():1629-31. PubMed ID: 9721418
[No Abstract] [Full Text] [Related]
16. Sucralfate for peptic ulcer--a reappraisal.
Med Lett Drugs Ther; 1984 Apr; 26(660):43-4. PubMed ID: 6323938
[No Abstract] [Full Text] [Related]
17. Colloidal bismuth subcitrate in peptic ulcer disease.
Tytgat GN
S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
[TBL] [Abstract][Full Text] [Related]
18. Maintenance treatment of patients with healed peptic ulcer with sucralfate, placebo and cimetidine.
Libeskind M
Scand J Gastroenterol Suppl; 1983; 83():69-70. PubMed ID: 6356324
[TBL] [Abstract][Full Text] [Related]
19. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
[No Abstract] [Full Text] [Related]
20. Comparison of omeprazole and placebo for bleeding peptic ulcer.
Srinath C
Trop Gastroenterol; 1997; 18(3):115-6. PubMed ID: 9385855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
